COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis
Author:
Funder
Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s13760-022-02121-w.pdf
Reference29 articles.
1. Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present, and future. J Clin Invest 116(11):2843–2854. https://doi.org/10.1172/JCI29894
2. Stankovic M, Peric S, Stojiljkovic Tamas O, Stankovic T, Nikolic A, Lavrnic D et al (2018) Quality of life in patients with MuSK positive myasthenia gravis. Acta Neurol Belg 118(3):423–427. https://doi.org/10.1007/s13760-018-0915-y
3. Basta I, Pekmezovic T, Peric S, Kisic-Tepavcevic D, Rakocevic-Stojanovic V, Stevic Z et al (2012) Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia). Neurol Sci 33(6):1375–1381. https://doi.org/10.1007/s10072-012-1170-2
4. Grob D, Brunner N, Namba T, Pagala M (2008) Lifetime course of myasthenia gravis. Muscle Nerve 37(2):141–149. https://doi.org/10.1002/mus.20950
5. Kowalik MM, Trzonkowski P, Łasińska-Kowara M, Mital A, Smiatacz T, Jaguszewski M (2020) COVID-19—toward a comprehensive understanding of the disease. Cardiol J 27(2):99–114. https://doi.org/10.5603/CJ.a2020.0065
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis;Heliyon;2024-01
2. Association between COVID‐19 and myasthenia gravis (MG): A genetic correlation and Mendelian randomization study;Brain and Behavior;2023-08-28
3. Myotonic dystrophy type 1 in the COVID-19 era;Neurological Sciences;2023-05-08
4. Global Needs and Barriers for Medical Research Education: Initiatives to Solve the Physician-Scientists Shortage;International Journal of Medical Students;2023-03-31
5. COVID-19 vaccination in myasthenia gravis: safe, but predictors of disease exacerbation yet to be determined;Neurological Sciences;2023-02-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3